CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2001-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.111583198PMID 11353871PMCID PMC33473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Examination of the Function of RANTES, MIP-1α, and MIP-1β following Interaction with Heparin-like Glycosaminoglycans*

  2000cited by this paper
• Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans.

  2000cited by this paper
• Cellular and Species Resistance to Murine Amphotropic, Gibbon Ape, and Feline Subgroup C Leukemia Viruses Is Strongly Influenced by Receptor Expression Levels and by Receptor Masking Mechanisms

  2000cited by this paper
• Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.

  1999cited by this paper
• Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques.

  1999cited by this paper
• In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A.

  1999cited by this paper
• The influenza haemagglutinin-induced fusion cascade: effects of target membrane permeability changes.

  1999cited by this paper
• Two Distinct Regions of Cyclophilin B Are Involved in the Recognition of a Functional Receptor and of Glycosaminoglycans on T Lymphocytes*

  1999cited by this paper
• Serial analysis of gene expression in a microglial cell line

  1999cited by this paper
• Host cyclophilin A mediates HIV‐1 attachment to target cells via heparans

  1999cited by this paper
• Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts

  1999cited by this paper
• CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA‐1/ICAM‐1 pathway

  1999cited by this paper
• Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.

  1999cited by this paper
• Establishment of a Functional Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcription Complex Involves the Cytoskeleton

  1998cited by this paper
• Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity.

  1998cited by this paper
• Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes.

  1998cited by this paper
• Human Immunodeficiency Virus Type 1 Replication Is Modulated by Host Cyclophilin A Expression Levels

  1998cited by this paper
• Human Immunodeficiency Virus Type 1 T-Lymphotropic Strains Enter Macrophages via a CD4- and CXCR4-Mediated Pathway: Replication Is Restricted at a Postentry Level

  1998cited by this paper
• The pattern of expression of CD147/neurothelin during human T-cell ontogeny as defined by the monoclonal antibody 8D6.

  1997cited by this paper
• Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence.

  1997cited by this paper
• Cyclophilin A-induced alterations of human immunodeficiency virus type 1 CA protein in vitro

  1997cited by this paper
• Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules.

  1997cited by this paper
• Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition

  1997cited by this paper
• Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A

  1997cited by this paper
• Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells

  1996cited by this paper
• Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction.

  1996cited by this paper
• Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription

  1996cited by this paper
• Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization

  1996cited by this paper
• Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A

  1996cited by this paper
• The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811

  1996cited by this paper
• Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses

  1996cited by this paper
• Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.

  1996cited by this paper
• Functional association of cyclophilin A with HIV-1 virions

  1994cited by this paper
• Specific incorporation of cyclophilin A into HIV-1 virions

  1994cited by this paper
• Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.

  1993cited by this paper
• Peptidylproline cis-trans-isomerases: immunophilins.

  1993cited by this paper
• Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera

  1993cited by this paper
• Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.

  1993cited by this paper
• Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.

  1992cited by this paper
• Leukocyte chemotactic activity of cyclophilin.

  1992cited by this paper
• Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.

  1992cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

  1990cited by this paper
• Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor.

  1989cited by this paper
• Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus

  1986cited by this paper

• Targeting gut surface proteins in Diaphorina citri by RNA interference reduces uptake of Candidatus Liberibacter asiaticus.

  2026cites this paper
• SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome

  2025cites this paper
• Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies

  2025cites this paper
• Cyclophilin–CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8

  2025cites this paper
• Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities

  2025cites this paper
• CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response

  2025cites this paper
• CD45 and Basigin (CD147) Are Functional Ligands for Galectin-8 on Human Leukocytes

  2025cites this paper
• CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target

  2025cites this paper
• Phenotyping of human platelets in response to platelet agonists and inhibitors using multiparameter flow cytometry and unbiased high-dimensional analysis

  2025cites this paper
• SARS‐CoV‐2: A Liver Brief

  2025influential citation
• CD147 mediates the adsorption of influenza A virus on the cell surface through direct interaction with HA

  2025cites this paper
• Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells

  2024cites this paper
• Metabolic Function and Therapeutic Potential of CD147 for Hematological Malignancies: An Overview

  2024cites this paper
• Changes in Erythrocytes and Their Degradation Products under the Influence of the SARS-COV-2 Virus

  2024cites this paper
• Research trends on alphavirus receptors: a bibliometric analysis

  2024cites this paper
• Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues

  2024cites this paper
• Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils

  2024cites this paper
• Human cytomegalovirus: pathogenesis, prevention, and treatment

  2024cites this paper
• A comprehensive investigation on the receptor BSG expression reveals the potential risk of healthy individuals and cancer patients to 2019-nCoV infection

  2024cites this paper
• A comprehensive review on targeting cluster of differentiation: An attractive strategy for inhibiting viruses through host proteins.

  2024cites this paper
• SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147

  2024cites this paper
• Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147

  2024cites this paper
• Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases

  2023cites this paper
• Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities

  2023cites this paper
• SARS-CoV-2 Receptors and Their Involvement in Cell Infection

  2023cites this paper
• Regulation of traction force through the direct binding of Basigin (CD147) and Calpain 4

  2023cites this paper
• Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147

  2023cites this paper
• CD147: an integral and potential molecule to abrogate hallmarks of cancer

  2023cites this paper
• Engineered Therapeutic Antibody Against SARS-CoV-2

  2023cites this paper
• Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147

  2023cites this paper
• Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR

  2023cites this paper
• Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis

  2023cites this paper
• Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19

  2023cites this paper
• Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus

  2023cites this paper
• Diabetes as a potential compounding factor in COVID-19-mediated male subfertility

  2022cites this paper
• T Lymphocytes as Targets for SARS-CoV-2

  2022cites this paper
• The Probable Mechanism of Hair Loss in Patients With COVID-19.

  2022cites this paper
• SARS-CoV-2 cell entry beyond the ACE2 receptor

  2022cites this paper
• The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies

  2022cites this paper
• Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants

  2022cites this paper
• Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2

  2022cites this paper
• A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody

  2022cites this paper
• SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes

  2022cites this paper
• Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?

  2022cites this paper
• SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner

  2022cites this paper
• Animal models for COVID-19: advances, gaps and perspectives

  2022cites this paper
• In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds

  2022cites this paper
• Computational Modeling of T Cell Hypersensitivity during Coronavirus Infections Leading to Autoimmunity and Lethality

  2022cites this paper
• SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability

  2022cites this paper
• Cyclophilin A is incorporated into cyprinid herpesvirus 3 (CyHV-3) virion via interaction with envelope VP32 and facilitates CyHV-3 replication in in vitro

  2022cites this paper
• A Role for Basigin in Toxoplasma gondii Infection

  2022cites this paper
• Recognition between CD147 and cyclophilin A deciphered by accelerated molecular dynamics simulations.

  2022cites this paper
• ACE2-Independent Alternative Receptors for SARS-CoV-2

  2022cites this paper
• Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

  2022cites this paper
• CD98hc in host-pathogen interactions: roles of the multifunctional host protein during infections.

  2022cites this paper
• Eyes on coronavirus

  2021cites this paper
• CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target

  2021cites this paper
• SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

  2021cites this paper
• Towards Tumor Targeting via Invasive Assay Using Magnetospirillum magneticum

  2021cites this paper
• Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein

  2021cites this paper
• Eyes on coronavirus

  2021cites this paper
• The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play

  2021cites this paper
• Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection

  2021cites this paper
• Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma

  2021cites this paper
• Eyes on coronavirus

  2021cites this paper
• The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play International Journal of Biological Macromolecules

  2021cites this paper
• Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection

  2021cites this paper
• SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2

  2021cites this paper
• CRISPR/Cas9 genome editing reveals an essential role for basigin in maintaining a nonkeratinized squamous epithelium in cornea

  2021cites this paper
• The Ok blood group system: an update

  2021cites this paper
• Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns

  2021cites this paper
• Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone.

  2021influential citation
• BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes

  2021cites this paper
• Diabetes as a compounding factor in COVID-19-mediated male subfertility

  2021cites this paper
• Alterations in platelets during SARS-CoV-2 infection

  2021cites this paper
• Meningococcus, this famous unknown.

  2021cites this paper
• Host factors: Implications in immunopathogenesis of COVID-19

  2021cites this paper
• Role of host factors in SARS-CoV-2 entry

  2021cites this paper
• Basigin drives intracellular accumulation of l-lactate by harvesting protons and substrate anions

  2021cites this paper
• Basigin-CyP elevated porcine circovirus type2 replication.

  2020cites this paper
• Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

  2020cites this paper
• Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System

  2020cites this paper
• Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells

  2020cites this paper
• Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia

  2020cites this paper
• COULD COVID-19 BE A HEMOGLOBINOPATHY?

  2020cites this paper
• Cyclophilin A is a mitochondrial factor that forms antiapoptotic complexes with p23

  2020cites this paper
• Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study

  2020cites this paper
• Vascular underpinning of COVID-19

  2020cites this paper
• Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2

  2020cites this paper
• Metabolic stress and disease-stage specific basigin expression of peripheral blood immune cell subsets in COVID-19 patients

  2020cites this paper
• IL-6: Relevance for immunopathology of SARS-CoV-2

  2020cites this paper
• Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease

  2020cites this paper
• Cyclosporin A suppresses Porphyromonas gingivalis lipopolysaccharide induced matrix metalloproteinases activities in the co-culture of human gingival fibroblasts and monocyte cell line THP-1

  2020cites this paper
• Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

  2020cites this paper
• Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy

  2020cites this paper
• Cyclophilin A is a mitochondrial factor that forms complexes with p23 – correlative evidence for an anti-apoptotic action

  2020cites this paper
• Resistance of endothelial cells to SARS-CoV-2 infection in vitro

  2020cites this paper
• SARS-CoV-2: Targeted managements and vaccine development

  2020cites this paper
• Entry of SARS-CoV2 through the Basal Surface of Alveolar Endothelial Cells – A Proposed Mechanism Mediated by CD147 in COVID-19

  2020cites this paper
• Do Blood Group Antigens and the Red Cell Membrane Influence Human Immunodeficiency Virus Infection?

  2020cites this paper